D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TERN holding history
Terns Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TERN overviewAll 13F holders of TERNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −201,191−100.0% | Sold out | Holders |
| Q1 2026 | 201,191 | $10.6M | <0.1% | −952,838−82.6% | Reduced | Holders |
| Q4 2025 | 1,154,029 | $46.6M | <0.1% | +1,154,029 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −57,341−100.0% | Sold out | Holders |
| Q4 2024 | 57,341 | $317.7K | <0.1% | +19,870+53.0% | Added | Holders |
| Q3 2024 | 37,471 | $312.5K | <0.1% | +10,506+39.0% | Added | Holders |
| Q2 2024 | 26,965 | $183.6K | <0.1% | +9,175+51.6% | Added | Holders |
| Q1 2024 | 17,790 | $116.7K | <0.1% | +17,790 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −46,762−100.0% | Sold out | Holders |
| Q1 2023 | 46,762 | $553.7K | <0.1% | +46,762 | New | Holders |